{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:33:18Z","timestamp":1747207998035,"version":"3.40.5"},"reference-count":23,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Biomark. Med."],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.2217\/bmm-2022-0884","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T12:51:48Z","timestamp":1686228708000},"page":"319-324","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Relationship Between Disease Severity and Myeloperoxidase in Chronic Viral Hepatitis: A Prospective Study"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8537-0195","authenticated-orcid":false,"given":"Arzu","family":"\u015eenol","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases & Clinical Microbiology, Fethi Sekin City Hospital, Elazig, 23100, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3722-4660","authenticated-orcid":false,"given":"\u015eafak","family":"\u00d6\u00a0Balin","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases & Clinical Microbiology, Faculty of Medicine, F\u0131rat University, Elazig, 23100, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.06.004"},{"key":"e_1_3_4_4_1","first-page":"1","article-title":"Treatment of hepatitis B in decompensated liver cirrhosis","volume":"2011","author":"Gua R","year":"2011","unstructured":"Gua R , LuiHF. Treatment of hepatitis B in decompensated liver cirrhosis. Int. J. Hepatol.2011, 1\u201311 (2011).","journal-title":"Int. J. Hepatol."},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2014.05.008"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.37973"},{"issue":"1","key":"e_1_3_4_7_1","first-page":"47","article-title":"Levels of malondialdehyde, myeloperoxidase and nitrotyrosine in patients with chronic viral hepatitis B and C","volume":"21","author":"Namiduru ES","year":"2012","unstructured":"Namiduru ES , NamiduruM, Tarak\u00e7io\u011fluM, TanriverdiM. Levels of malondialdehyde, myeloperoxidase and nitrotyrosine in patients with chronic viral hepatitis B and C. Adv. Clin. Exp. Med.21(1), 47\u201353 (2012).","journal-title":"Adv. Clin. Exp. Med."},{"issue":"1","key":"e_1_3_4_8_1","first-page":"15","article-title":"Protein oxidative modifications: beneficial roles in disease and health","volume":"1","author":"Cai Z","year":"2013","unstructured":"Cai Z , YanLJ. Protein oxidative modifications: beneficial roles in disease and health. J. Biochem. Pharmacol. Res.1(1), 15\u201326 (2013).","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2015.08.012"},{"key":"e_1_3_4_10_1","first-page":"75","article-title":"Diagnostic and predictive values of serum and acid fluid TNF-alpha, interleukin-6, nitric oxide, and myeloperoxidase in patients with neutrocytic acid cirrhosis","volume":"19","author":"Harmandar FA","year":"2020","unstructured":"Harmandar FA , HarmandarIO, TezelIA. Diagnostic and predictive values of serum and acid fluid TNF-alpha, interleukin-6, nitric oxide, and myeloperoxidase in patients with neutrocytic acid cirrhosis. Turk. J. Acad. Gastroenterol.19, 75\u201382 (2020).","journal-title":"Turk. J. Acad. Gastroenterol."},{"key":"e_1_3_4_11_1","unstructured":"European Association for the Study of the Liver\n. Clinical practice guidelines on the management of hepatitis B virus infection (2017). www.easl.eu\/medias\/cpg\/management-of-hepatitis-B-virus-infection\/English-report.pdf"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80226-6"},{"key":"e_1_3_4_13_1","first-page":"1","article-title":"The roles of neutrophils in the pathogenesis of liver diseases","volume":"12","author":"Tang J","year":"2021","unstructured":"Tang J , YanZ, FengQet al. The roles of neutrophils in the pathogenesis of liver diseases. Front. Immunol.12, 1\u201311 (2021).","journal-title":"Front. Immunol."},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.5455\/jtomc.2016.02.024"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(79)90630-2"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2006.11.001"},{"issue":"3","key":"e_1_3_4_17_1","first-page":"273","article-title":"Oxidative stress and antioxidant defense in patients with chronic hepatitis B","volume":"58","author":"Fisgin NT","year":"2012","unstructured":"Fisgin NT , AydinBK, SarikayaHet al. Oxidative stress and antioxidant defense in patients with chronic hepatitis B. Clin. Lab.58(3\u20134), 273\u2013280 (2012).","journal-title":"Clin. Lab."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i29.2880"},{"issue":"4","key":"e_1_3_4_19_1","first-page":"1","article-title":"Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis","volume":"26","author":"Kothari N","year":"2010","unstructured":"Kothari N , KeshariRS, BograJet al. Increased myeloperoxidase enzyme activity in plasma is an indicator of inflammation and onset of sepsis. J. Crit. Care26(4), 1\u20137 (2010).","journal-title":"J. Crit. Care"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1179\/1351000214Y.0000000101"},{"issue":"4","key":"e_1_3_4_21_1","first-page":"254","article-title":"Plasma myeloperoxidase activity and apolipoprotein A-1 expression in chronic hepatitis B patients","volume":"14","author":"Mohamadkhani A","year":"2011","unstructured":"Mohamadkhani A , JaziiFR, SayehmiriKet al. Plasma myeloperoxidase activity and apolipoprotein A-1 expression in chronic hepatitis B patients. Arch. Iran. Med.14(4), 254\u2013258 (2011).","journal-title":"Arch. Iran. Med."},{"issue":"1","key":"e_1_3_4_22_1","first-page":"17","article-title":"Relationship between antioxidant capacity and oxidative stress in patients with chronic hepatitis B","volume":"4","author":"G\u00fcler SA","year":"2014","unstructured":"G\u00fcler SA , TolunFI, UcmakH, HaskayaG, YavuzM. Relationship between antioxidant capacity and oxidative stress in patients with chronic hepatitis B. Adv. Lab. Med. Int.4(1), 17\u201325 (2014).","journal-title":"Adv. Lab. Med. Int."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180615"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874315300902010001"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.07.322"}],"container-title":["Biomarkers in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/bmm-2022-0884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:39:28Z","timestamp":1719124768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/bmm-2022-0884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.2217\/bmm-2022-0884"],"URL":"https:\/\/doi.org\/10.2217\/bmm-2022-0884","relation":{},"ISSN":["1752-0363","1752-0371"],"issn-type":[{"type":"print","value":"1752-0363"},{"type":"electronic","value":"1752-0371"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibmm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}